Burel Pharmaceuticals recalls

Burel Pharmaceuticals has 8 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 7 Dec 2016. The most frequent reason is potency & assay.

Total recalls8since 2016

Last 12 months0reported

Class I00% of total

Ongoing0latest 7 Dec 2016

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 8 100%Class III 0 0%

Why burel pharmaceuticals is recalled

Potency & Assay8100%

By year

20168100%

All burel pharmaceuticals recalls, newest first

8 total

Reported	Class	Recall	Company	Reason	Where
7 Dec 2016Drug	CLASS II	Urolet MB Urinary Antiseptic, Antispasmodic Tablets recalled	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Urophen MB Urinary Antiseptic Tablets, Each tablet contains recalled	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Indiomin MB Urinary Antiseptic, Antispasmodic Capsules recalled	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Hyolev MB Urinary Antiseptic Tablets, Each tablet recalled	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Uramit MB Urinary Antiseptic Capsules recalled by Burel Pharmaceuticals	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Phenazopyridine Hydrochloride Tablets, USP, 100 mg recalled	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Azuphen MB Urinary Antiseptic Capsules recalled by Burel Pharmaceuticals	Burel Pharmaceuticals	Potency & Assay	Nationwide
7 Dec 2016Drug	CLASS II	Phenazopyridine Hydrochloride Tablets, USP, 200 mg recalled	Burel Pharmaceuticals	Potency & Assay	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.